FindTrial
Sign In

Upper hair follicle transplantation for the treatment of residual leukoplakia in the recipient site after surgical treatment of vitiligo

Upper hair follicle transplantation for the treatment of residual leukoplakia in the recipient site after surgical treatment of vitiligo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060913
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Treatment Group:upper hair follicle transplantation
Control Group:punch

Sponsors

Hangzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with stable vitiligo; 2.Patients who can tolerate the surgery, without any other systemic diseases except for vitiligo; 3.Patients who received the surgical treatment for more than 1 year, with poor repigmentation in the recipient sites.

Exclusion criteria

Exclusion criteria: 1.Patients with coagulation dysfunction; 2.Patients with fever, acute systemic infection or local infection in the surgical areas; 3.Local or systemic use of medical for the treatment of vitiligo in recent 3 months.

Design outcomes

Primary

MeasureTime frame
size of repigmentation;—

Countries

China

Contacts

Public ContactYi Wu
liuxingdejiban@163.com15000022917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026